Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Beta Amyloid 42 Measurement

Known as: Amyloid Beta 1-42 Measurement, Amyloid Beta 42 Protein, Beta Amyloid 1-42 Measurement 
The determination of the amount of the 1-42 amino acid beta amyloid protein isoform present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
The transmembrane protein CD33 is a sialic acid-binding immunoglobulin-like lectin that regulates innate immunity but has no… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.
OBJECTIVE Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional… Expand
Is this relevant?
2010
2010
Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells
Human brains harbor herpes simplex virus type-1 (HSV-1) DNA, which normally remains quiescent throughout many decades of life… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury.
OBJECT Damage to axons contributes to postinjury disabilities and is commonly observed following traumatic brain injury (TBI… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.
BACKGROUND To date, there have been no reports of individuals who have been characterized longitudinally using clinical and… Expand
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease
Microglia are the immune cells of the brain, they are activated in the brain of Alzheimer's disease (AD) patients and mouse… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42
More than 130 known mutations in the presenilin-1 (PS1) gene result in familial Alzheimer's disease (FAD) with a mutation… Expand
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury
Objective: To determine whether CSF amyloid beta 1-42 (Aβ-42) and tau have predictive value for prognosis after head injury… Expand
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.
Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a lower risk of developing Alzheimer's disease… Expand
Is this relevant?
1999
1999
Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease.
Families bearing mutations in the presenilin 1 (PS1) gene develop early onset familial Alzheimer's disease (FAD). Further, some… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE